Comprehensive CMC Support Sannova provides end-to-end CMC support from characterization to commercialization with fast, personalized service for complex, novel, and generic therapeutics, making it a strong partner for biotech and pharma developers needing integrated solutions and reliable on-time delivery.

Growth and Partnership Momentum Active investor involvement and leadership changes suggest strategic growth and opportunities to partner with PE-backed firms or portfolio companies seeking CRO support through scale-up and program acceleration.

Flexible Mid-Sized Capacity Mid-sized capacity with a dedicated lab and specialized focus offers a flexible, high-touch CRO option that can scale with client programs without the rigidity of larger CROs.

Regional Proximity Advantage Strategic Northeast US location enables close collaboration with East Coast biopharma networks, faster project kick-offs, and easier on-site interactions for US-based development programs.

Digital Outreach Ready Modern marketing and customer engagement tools alongside a reputation for fast, personalized delivery indicate strong potential for targeted outreach, early engagement, and efficient conversion of prospects.